Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Neuropharmacology. 2012 Jul 20;63(6):1002–1011. doi: 10.1016/j.neuropharm.2012.07.022

Fig. 4.

Fig. 4

Inhibition of acetylcholine-induced intracellular calcium response by mecamylamine, d-tubocurarine, bupropion or TMPH in HEK293 cell lines stably expressing human nicotinic acetylcholine receptor subtypes α3β4, α3β4α5D or α3β4α5N. Cells were stimulated with 1 mM acetylcholine in the presence of 10 mM Ca2+. Atropine (200 nM) was added to block muscarinic receptors. TMPH = 2,2,6,6-tetramethylpiperidin-4-yl heptanoate. n = 10–12. Results are given as means of normalized response ± SEM. Curves are normalized to the response at 0 μM of antagonist within each cell line.